Vita Coco director granted 1,530 deferred RSUs

Vita Coco Company, Inc. director Kenneth Sadowsky reported a routine equity compensation grant.

Rhea-AI Filing Summary

Vita Coco Company, Inc. director Kenneth Sadowsky reported a routine equity compensation grant. He received 1,530 shares of Common Stock as deferred restricted stock units (RSUs) that vest in full on the earlier of the day before the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, as long as he remains in continuous service. These deferred RSUs will settle on June 3, 2031, with each unit delivering one share of common stock. After this grant, Sadowsky directly holds 584,196 shares of Common Stock. He also holds a fully vested, currently exercisable non-qualified stock option covering 27,300 shares of Common Stock at an exercise price of $10.178 per share, expiring on January 2, 2030.

Insider Trade Summary

Grant/Award: 1,530 shares

Grant/Award 2 txns

Insider Sadowsky Kenneth

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,530	$75.18	$115K
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Common Stock — 584,196 shares (Direct); Non-Qualified Stock Option (Right to Buy) — 27,300 contracts (Direct)

Footnotes (2)

1. F1. Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on June 3, 2031. Each deferred RSU represents the right to receive one share of common stock of the Issuer.
2. F2. The stock option is fully vested and currently exercisable.

Key Figures

Deferred RSU grant: 1,530 shares Shares held after grant: 584,196 shares Option exercise price: $10.178 per share +3 more

6 metrics

Deferred RSU grant 1,530 shares Deferred RSUs granted to director on June 3, 2026

Shares held after grant 584,196 shares Common Stock directly owned following transaction

Option exercise price $10.178 per share Non-qualified stock option strike price

Option underlying shares 27,300 shares Common Stock underlying non-qualified stock option

Option expiration date January 2, 2030 Non-qualified stock option expiry

RSU settlement date June 3, 2031 Date deferred RSUs settle into common shares

Key Terms

deferred RSUs, 2021 Incentive Award Plan, Non-Qualified Stock Option (Right to Buy), vest in full, +1 more

5 terms

deferred RSUs financial

"Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full..."

2021 Incentive Award Plan financial

"Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full..."

Non-Qualified Stock Option (Right to Buy) financial

"Non-Qualified Stock Option (Right to Buy) ... underlying security title Common Stock"

vest in full financial

"RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of..."

continuous service financial

"provided that the Reporting Person remains in continuous service on the applicable vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Vita Coco (COCO) director Kenneth Sadowsky report?

Kenneth Sadowsky reported receiving 1,530 deferred RSUs of Vita Coco common stock as equity compensation. These RSUs are part of a grant under the 2021 Incentive Award Plan and are not an open-market stock purchase or sale.

How and when do Kenneth Sadowsky’s new Vita Coco (COCO) RSUs vest?

The 1,530 deferred RSUs vest in full on the earlier of the day before the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, provided Sadowsky remains in continuous service on the vesting date.

When will Kenneth Sadowsky’s Vita Coco (COCO) deferred RSUs settle into shares?

The deferred RSUs will settle on June 3, 2031, when each unit converts into one share of Vita Coco common stock. Until settlement, they function as a right to receive shares in the future rather than current stock ownership.

How many Vita Coco (COCO) shares does Kenneth Sadowsky hold after this Form 4?

Following the reported grant, Kenneth Sadowsky directly holds 584,196 shares of Vita Coco common stock. This total reflects his ownership after receiving the 1,530-share deferred RSU award disclosed in the filing.

What stock options does Kenneth Sadowsky hold in Vita Coco (COCO)?

Sadowsky holds a fully vested, currently exercisable non-qualified stock option for 27,300 shares of Vita Coco common stock with an exercise price of $10.178 per share. The option is scheduled to expire on January 2, 2030.

Is the Vita Coco (COCO) Form 4 a sign of insider buying or a compensation grant?

The Form 4 reflects a compensation-related grant, not open-market insider buying. The 1,530 shares are deferred RSUs awarded under the company’s 2021 Incentive Award Plan, vesting over time and settling into stock in 2031.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 04:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sadowsky Kenneth

(Last) (First) (Middle)

111 5TH AVENUE 2ND FLOOR

(Street)

NEW YORK NEW YORK 10003

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		A		1,530(1)	A	$75.18	584,196	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$10.178							(2)	01/02/2030	Common Stock	27,300		27,300	D

Explanation of Responses:

1. Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on June 3, 2031. Each deferred RSU represents the right to receive one share of common stock of the Issuer.

2. The stock option is fully vested and currently exercisable.

	/s/ Alison Klein, Attorney-in-Fact for Kenneth Sadowsky	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)